Canakinumab

ATC L04AC08 · 9 markets · 16 records

Canakinumab 9 markets · 16 records Forms

US 3 records · 2 strengths

Records without a stated strength · 1 GUNA-ANTI IL 1

GB 3 records · 2 strengths

  • 150 mginjectionIlaris 150mg powder for solution for injection vials also in US·AU·TW
  • 150 mg/1 mLinjectionIlaris 150mg/1ml solution for injection pre-filled pensIlaris 150mg/1ml solution for injection vials also in ES

AU 2 records · 2 strengths

  • 150 mginjectionILARIS canakinumab 150mg/1mL solution for injection in vials also in US·GB·TW unknown

Records without a stated strength · 1 Ilaris

CA 1 records · 1 strengths

ES 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 ILARIS SOLUTION FOR INJECTION 150MG/ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Ilaris

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.